Investing
Cathie Wood's ARK Invest Buys Over 7 Million Shares of This Biotech-Focused SPAC
Published:
A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 7 million shares of Soaring Eagle Acquisition Corp. (NASDAQ: SRNG) on Monday, as the share price of these exchange-traded funds were up around 1% in the day’s session. Their share prices have greatly improved over the past year.
Specifically, ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 4,512,926 shares of the special purpose acquisition company (SPAC), and ARK Innovation ETF (NYSEARCA: ARKK) bought 2,506,461 shares. At Monday’s closing prices, this would have valued this purchase at roughly $70.2 million. This is only a small fraction of the total holdings. ARKG is up 57% over the past 52 weeks and ARKK is up 54%.
Here is a quick look at all the purchases made by ARK ETFs:
Fund | Ticker | Company | Shares |
---|---|---|---|
ARKG | ADPT | Adaptive Biotechnologies | 232,610 |
ARKG | SRNG | Soaring Eagle Acquisition | 4,512,926 |
ARKG | SGFY | Signify Health | 30,490 |
ARKK | Z | Zillow | 101,994 |
ARKK | TSP | TuSimple | 316,814 |
ARKK | SRNG | Soaring Eagle Acquisition | 2,506,461 |
ARKQ | MKFG | Markforged | 57,406 |
ARKQ | PATH | UiPath | 8,178 |
ARKW | LPSN | LivePerson | 22,696 |
ARKW | Z | Zillow | 24,750 |
ARKW | PATH | UiPath | 8,641 |
ARKX | BLDE | Blade Air Mobility | 16,370 |
ARKX | KTOS | Kratos Defense & Security Solutions | 49,634 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.